Literature DB >> 16677240

Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults.

U Bodtger1, L K Poulsen, A Linneberg.   

Abstract

BACKGROUND: Rhinitis symptoms and IgE-sensitization often mismatch. Asymptomatic sensitization is an established risk factor for later rhinitis, whereas it is not clear whether rhinitis is a risk factor for later development of IgE-sensitization.
OBJECTIVE: To investigate whether nonallergic rhinitis is a risk factor for later development of IgE-sensitization in adults during an 8-year follow-up period, and whether asymptomatic sensitization is a risk factor for later development of rhinitis.
METHODS: In a population-based study of 15-69 years olds in 1990, 734 subjects were re-examined in 1998. On both occasions questionnaires on rhinitis symptoms were completed and serum IgE (against birch, grass, mugwort, cat, dog, and Dermatophagoides pteronyssinus) were determined (positive if >or=0.35 kUA/l). Asymptomatic sensitization: positive IgE levels without any rhinitis symptoms. Nonallergic rhinitis: rhinitis symptoms and no sensitization.
RESULTS: Asymptomatic sensitization to pollens, pets, or house dust mite was significantly associated with onset of rhinitis symptoms, also when changing baseline cut-off for sensitization to >or=0.1 or >or=0.7 kUA/l. The 8-year incidence of pollen-related rhinitis was 15.1% and 2.6% in subjects sensitized and nonsensitized to pollens, respectively (odds ratio 6.1, 95% CI 2.3-16.0). Persistent or intermittent nonallergic rhinitis was not significantly associated with later sensitization, yet a positive trend for development was observed in nonallergic pollen-related rhinitis.
CONCLUSION: Asymptomatic sensitization but not nonallergic rhinitis was a significant risk factor for later development of allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677240     DOI: 10.1111/j.1398-9995.2006.01140.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

1.  Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study.

Authors:  Yasuhiro Uekusa; Ayako Inamine; Syuji Yonekura; Shigetoshi Horiguchi; Takashi Fujimura; Daijyu Sakurai; Heizaburo Yamamoto; Homare Suzuki; Toyoyuki Hanazawa; Yoshitaka Okamoto
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

Review 2.  Component resolved testing for allergic sensitization.

Authors:  Kirsten Skamstrup Hansen; Lars K Poulsen
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

3.  Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients.

Authors:  Mihaela Zidarn; Maša Robič; Anja Krivec; Mira Šilar; Yvonne Resch-Marat; Susanne Vrtala; Peter Kopač; Nissera Bajrović; Rudolf Valenta; Peter Korošec
Journal:  Clin Exp Allergy       Date:  2019-02-27       Impact factor: 5.018

4.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

5.  [Local allergic rhinitis to Alternaria alternata : Evidence for local IgE production exclusively in the nasal mucosa].

Authors:  L Klimek; C Bardenhewer; M Spielhaupter; C Harai; K Becker; O Pfaar
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

Review 6.  [Local (exclusive) IgE production in the nasal mucosa. Evidence for local allergic rhinitis].

Authors:  L Klimek; L von Bernus; O Pfaar
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

7.  Allergic rhinitis, bronchial asthma and other allergies in patients with Alzheimer's disease: unnoticed issue.

Authors:  Andrzej Bożek; Piotr Bednarski; Jerzy Jarzab
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

8.  A clear urban-rural gradient of allergic rhinitis in a population-based study in Northern Europe.

Authors:  Stine Holmegaard Christensen; Signe Timm; Christer Janson; Bryndis Benediktsdóttir; Bertil Forsberg; Mathias Holm; Rain Jogi; Ane Johannessen; Ernst Omenaas; Torben Sigsgaard; Cecilie Svanes; Vivi Schlünssen
Journal:  Eur Clin Respir J       Date:  2016-11-25

Review 9.  Pharmacological Management of Allergic Rhinitis in the Elderly.

Authors:  Andrzej Bozek
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

Review 10.  Epidemiology and natural history of atopic diseases.

Authors:  Simon F Thomsen
Journal:  Eur Clin Respir J       Date:  2015-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.